What STD Looks Like Cauliflower: Genital Warts

The STD that looks like cauliflower is genital warts, caused by the human papillomavirus (HPV). These growths appear as small, skin-colored bumps that cluster together into a rough, irregular shape resembling a cauliflower floret. Over 90% of genital wart cases are caused by two specific low-risk strains of HPV: types 6 and 11.

What Genital Warts Look Like

Genital warts start as small swellings in the genital area. Individually, they often look like tiny, soft bumps that are skin-colored or slightly darker. When several warts grow close together, they merge into the distinctive cauliflower-like clusters most people recognize. The surface is uneven and textured, not smooth like a skin tag or mole.

Size varies widely. Some warts are barely visible, just a millimeter or two across. Others grow into larger clusters several centimeters wide, especially if left untreated. They’re usually painless, though some people experience mild itching. The warts tend to appear in moist, warm areas of the body: the vulva, vaginal walls, cervix, penis shaft, scrotum, and around the anus. They can also show up in the groin folds or upper thighs.

How HPV Spreads and When Warts Appear

HPV spreads through skin-to-skin sexual contact, including vaginal, anal, and oral sex. Condoms reduce the risk but don’t eliminate it completely, since the virus can live on skin not covered by a condom. You don’t need to have visible warts to pass the infection to a partner.

One of the trickiest things about genital warts is the timeline. After exposure, it can take weeks to months before any visible growth appears. Some people carry the virus for a long time without ever developing warts, which makes it difficult to pinpoint when or from whom the infection came. This long incubation period also means a new partner isn’t necessarily the source.

Low-Risk vs. High-Risk HPV

HPV types 6 and 11, the strains behind the cauliflower-like warts, are classified as low-risk. That means they have very low potential to turn into cancer. This is an important distinction, because other HPV strains (types 16 and 18, for example) are high-risk and linked to cervical, anal, and throat cancers, but those strains rarely produce visible warts.

In other words, the warts themselves are a cosmetic and emotional burden more than a cancer risk. That said, it’s possible to be infected with both low-risk and high-risk HPV strains at the same time, so routine screening (like Pap smears) still matters.

Conditions That Look Similar

Not every bump in the genital area is a wart. A few common, harmless conditions get mistaken for genital warts regularly:

  • Pearly penile papules: Tiny, smooth, dome-shaped bumps that ring the head of the penis in neat rows. They’re a normal anatomical variation, not an infection.
  • Vestibular papillomatosis: Small, finger-like projections on the inner labia. These are symmetrical and uniform, unlike the irregular clusters of warts.
  • Skin tags: Soft, smooth flaps of skin that hang from a thin stalk. They lack the rough, bumpy texture of warts.

The key visual difference is texture and pattern. Genital warts are irregular, rough-surfaced, and tend to cluster. The harmless lookalikes are typically smooth, symmetrical, and evenly spaced.

How Genital Warts Are Diagnosed

Doctors usually diagnose genital warts by looking at them. No blood test or swab is needed in most cases, and HPV testing is actually not recommended for wart diagnosis because it doesn’t change how the warts are managed. A biopsy (removing a small tissue sample) is only necessary when the growths look unusual: pigmented, bleeding, ulcerated, or firmly attached to deeper tissue. A biopsy may also be recommended if the warts don’t respond to treatment, or if you’re immunocompromised.

Treatment and What to Expect

Genital warts can be treated, but the underlying HPV infection doesn’t have a cure. The goal of treatment is to remove the visible warts. Your immune system handles the virus itself over time, and most people clear the infection within one to two years.

Treatment options fall into two categories. The first is topical: prescription creams or solutions that you apply at home over several weeks. These work by either destroying wart tissue directly or boosting the local immune response to fight the virus. The second is in-office procedures, where a provider removes the warts using freezing (cryotherapy), laser treatment, or minor surgical excision. Larger or stubborn clusters often respond better to in-office removal.

Recurrence is common. Even after successful treatment, warts come back in a significant number of cases, particularly in the first few months. This doesn’t mean treatment failed. It means the virus was still active beneath the skin when the visible warts were removed. Repeat treatments are normal.

Genital Warts During Pregnancy

Genital warts can grow faster and larger during pregnancy due to changes in immune function and increased blood flow to the genital area. Enlarged warts can occasionally interfere with vaginal delivery. There is also a small risk of passing HPV types 6 and 11 to the baby during birth, which can lead to a rare condition called recurrent respiratory papillomatosis, where wart-like growths develop in the infant’s airway. This is uncommon, but it’s something your obstetric provider should know about if you have a history of genital warts.

Prevention With the HPV Vaccine

The HPV vaccine (Gardasil 9) protects against nine HPV strains, including types 6 and 11. In clinical trials, the vaccine was 99% effective at preventing genital warts when given to people who hadn’t already been exposed to those strains. It’s routinely recommended starting at age 11 or 12, but it can be given up to age 45.

Vaccination before any sexual contact offers the strongest protection, since it works best against strains you haven’t encountered yet. Even if you’ve already had one HPV type, the vaccine still protects against the others it covers. Countries with high vaccination rates have seen dramatic drops in genital wart diagnoses within just a few years of introducing the vaccine.